Słoczyńska Karolina, Powroźnik Beata, Pękala Elżbieta, Waszkielewicz Anna M
Department of Bioorganic Chemistry, Chair of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688, Krakow, Poland,
J Appl Genet. 2014 May;55(2):273-85. doi: 10.1007/s13353-014-0198-9. Epub 2014 Mar 11.
Mutagenicity refers to the induction of permanent changes in the DNA sequence of an organism, which may result in a heritable change in the characteristics of living systems. Antimutagenic agents are able to counteract the effects of mutagens. This group of agents includes both natural and synthetic compounds. Based on their mechanism of action among antimutagens, several classes of compounds may be distinguished. These are compounds with antioxidant activity; compounds that inhibit the activation of mutagens; blocking agents; as well as compounds characterized with several modes of action. It was reported previously that several antitumor compounds act through the antimutagenic mechanism. Hence, searching for antimutagenic compounds represents a rapidly expanding field of cancer research. It may be observed that, in recent years, many publications were focused on the screening of both natural and synthetic compounds for their beneficial muta/antimutagenicity profile. Thus, the present review attempts to give a brief outline on substances presenting antimutagenic potency and their possible mechanism of action. Additionally, in the present paper, a screening strategy for mutagenicity testing was presented and the characteristics of the most widely used antimutagenicity assays were described.
致突变性是指生物体DNA序列发生永久性改变,这可能导致生命系统特征的可遗传变化。抗诱变剂能够抵消诱变剂的作用。这类试剂包括天然和合成化合物。根据抗诱变剂的作用机制,可以区分出几类化合物。这些是具有抗氧化活性的化合物;抑制诱变剂活化的化合物;阻断剂;以及具有多种作用方式的化合物。此前有报道称,几种抗肿瘤化合物通过抗诱变机制发挥作用。因此,寻找抗诱变化合物是癌症研究中一个迅速发展的领域。可以观察到,近年来,许多出版物都集中在筛选天然和合成化合物的有益诱变/抗诱变特性。因此,本综述试图简要概述具有抗诱变潜力的物质及其可能的作用机制。此外,本文还介绍了诱变测试的筛选策略,并描述了最广泛使用的抗诱变测定方法的特点。